Cellulose Filter Beta-Glucan Reduction via Carbonate Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Cellulose-containing filters used in biopharmaceutical and plasma purification processes release beta-glucan leachables, which exceed regulatory thresholds, posing safety and compliance risks.
Innovation Solution
Treating cellulose-containing filter materials with a carbonate-containing solution, including carbonate salts or organic carbonates, to reduce leachable beta-glucans, thereby minimizing their presence in biopharmaceutical or plasma derivatives.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If cellulose-containing filter materials are used in biopharmaceutical and plasma purification processes, then filtration effectiveness is improved, but beta-glucan leachables increase beyond regulatory thresholds
Solution Approach 1:
The filter material is treated with carbonate-containing solutions (sodium carbonate, potassium carbonate, ammonium carbonate, or carbonic acid) before being used in filtration processes. This preliminary treatment modifies the cellulose matrix to reduce beta-glucan leachability, allowing the filter to maintain its filtration effectiveness while generating fewer harmful beta-glucan leachables during subsequent biopharmaceutical or plasma purification operations
2Ease of manufacture
If standard cellulose filters are used without treatment, then manufacturing simplicity is maintained, but beta-glucan levels in the product stream exceed regulatory limits
Solution Approach 1:
The chemical composition parameters of the filter material are modified by introducing carbonate-containing treatments. This changes the chemical properties of the cellulose matrix, specifically reducing the leachability of beta-glucans. The treatment can be applied as a pre-step in the manufacturing process, allowing control over beta-glucan impurity levels in the final filtered product while maintaining a relatively simple manufacturing approach
3Device complexity
If untreated cellulose filter materials are used, then process simplicity is maintained, but patient safety is compromised due to elevated beta-glucan levels
Solution Approach 1:
The carbonate-containing treatment, which modifies the cellulose structure, converts the potentially harmful beta-glucan leachables into a controlled parameter. The treatment process itself is simple and can be integrated into existing filtration workflows, but it effectively reduces the harmful beta-glucan levels to below regulatory thresholds, thereby protecting patient safety without significantly increasing process complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly reduces beta-glucan levels in filter materials by up to 99%, ensuring biopharmaceutical or plasma derivatives have impurity levels below regulatory limits, enhancing patient safety and compliance.
Implementation Method 1
treating the filter material with a solution comprising a carbonate salt, an organic carbonate (such as a carbonate ester), or carbonic acid
Data Source
AI summary
Treatment methods for reduction of (1→3)-β-D-glucan leachables from cellulose-containing filter materials are described.